Beihai Gofar Marine Biological Industry Co Ltd (600538) - Total Liabilities
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has total liabilities worth CN¥181.58 Million CNY (≈ $26.57 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Beihai Gofar Marine Biological Industry to track the company's year-over-year net asset growth rate.
Beihai Gofar Marine Biological Industry Co Ltd - Total Liabilities Trend (1999–2025)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Beihai Gofar Marine Biological Industry (600538) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IGB Commercial Real Estate Investment Trust Unit
KLSE:5299
|
Malaysia | RM1.03 Billion |
|
Immobiliere Dassault SA
PA:IMDA
|
France | €355.32 Million |
|
Swedencare publ AB
ST:SECARE
|
Sweden | Skr2.84 Billion |
|
Source Capital Closed Fund
NYSE:SOR
|
USA | $5.30 Million |
|
Kolte - Patil Developers Limited
NSE:KOLTEPATIL
|
India | Rs63.53 Billion |
|
Doright Co.Ltd.
SHE:300950
|
China | CN¥425.70 Million |
|
Aurora Corp
TW:2373
|
Taiwan | NT$9.26 Billion |
|
Korea Petro Chemical Ind
KO:006650
|
Korea | ₩618.86 Billion |
Liability Composition Analysis (1999–2025)
This chart breaks down Beihai Gofar Marine Biological Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Beihai Gofar Marine Biological Industry stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beihai Gofar Marine Biological Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beihai Gofar Marine Biological Industry Co Ltd (1999–2025)
The table below shows the annual total liabilities of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥196.03 Million ≈ $28.69 Million |
+9.30% |
| 2024-12-31 | CN¥179.36 Million ≈ $26.25 Million |
+1.78% |
| 2023-12-31 | CN¥176.22 Million ≈ $25.79 Million |
-3.27% |
| 2022-12-31 | CN¥182.17 Million ≈ $26.66 Million |
+13.74% |
| 2021-12-31 | CN¥160.16 Million ≈ $23.44 Million |
-25.21% |
| 2020-12-31 | CN¥214.15 Million ≈ $31.34 Million |
+105.05% |
| 2019-12-31 | CN¥104.44 Million ≈ $15.28 Million |
-16.99% |
| 2018-12-31 | CN¥125.82 Million ≈ $18.41 Million |
+7.01% |
| 2017-12-31 | CN¥117.57 Million ≈ $17.20 Million |
-56.28% |
| 2016-12-31 | CN¥268.93 Million ≈ $39.35 Million |
+9.24% |
| 2015-12-31 | CN¥246.18 Million ≈ $36.02 Million |
-5.88% |
| 2014-12-31 | CN¥261.57 Million ≈ $38.28 Million |
-54.84% |
| 2013-12-31 | CN¥579.21 Million ≈ $84.76 Million |
+10.88% |
| 2012-12-31 | CN¥522.38 Million ≈ $76.44 Million |
+3.46% |
| 2011-12-31 | CN¥504.93 Million ≈ $73.89 Million |
+4.91% |
| 2010-12-31 | CN¥481.29 Million ≈ $70.43 Million |
-34.61% |
| 2009-12-31 | CN¥736.06 Million ≈ $107.71 Million |
-16.53% |
| 2008-12-31 | CN¥881.78 Million ≈ $129.03 Million |
+8.15% |
| 2007-12-31 | CN¥815.31 Million ≈ $119.30 Million |
+5.65% |
| 2006-12-31 | CN¥771.73 Million ≈ $112.93 Million |
+7.73% |
| 2005-12-31 | CN¥716.35 Million ≈ $104.82 Million |
+36.96% |
| 2004-12-31 | CN¥523.05 Million ≈ $76.54 Million |
+100.14% |
| 2003-12-31 | CN¥261.34 Million ≈ $38.24 Million |
+198.04% |
| 2002-12-31 | CN¥87.69 Million ≈ $12.83 Million |
+14.61% |
| 2001-12-31 | CN¥76.51 Million ≈ $11.20 Million |
-15.46% |
| 2000-12-31 | CN¥90.50 Million ≈ $13.24 Million |
+33.42% |
| 1999-12-31 | CN¥67.83 Million ≈ $9.93 Million |
-- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly… Read more